Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
SESSION 9: THERAPEUTIC APPROACHES TO FRONT LINE OVARIAN CANCER
Optimizing Outcomes for Patients Dispositioned to NACT; Is HIPEC the Savior?
Friday, April 29, 2022
11:45 AM – 12:05 PM
Speaker(s)
Oliver Zivanovic, MD
Memorial Sloan Kettering Cancer Center
New York, New York
Learning Objectives:
Describe current and emerging targets in platinum-resistant ovarian cancer (OC) treatment
Identify challenges in platinum-resistant OC management
Evaluate clinical data and surrounding emerging therapies for platinum-resistant OC